References
- Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, updated 2010 [Internet]. Bethesda, MD: GOLD; c2010 [cited 2011 May 13]. Available from: http://www.goldcopd.com/download.asp?intId=617.
- Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med 2010;16:97-105. https://doi.org/10.1097/MCP.0b013e328335df1e
- Joos GF. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease. Expert Opin Investig Drugs 2010;19:257-64. https://doi.org/10.1517/13543780903505084
- Kim SJ, Kim MS, Lee SH, Kim YK, Moon HS, Park SH, et al. A comparison of tiotropium 18 microgram, once daily and ipratropium 40 microgram, 4 times daily in a double-blind, double-dummy, efficacy and safety study in adults with chronic obstructive pulmonary disease. Tuberc Respir Dis 2005;58:498-506. https://doi.org/10.4046/trd.2005.58.5.498
- Levenson M. Long-acting beta-agonists and adverse asthma events meta-analysis [Internet]. Silver Spring, MD: US Food and Drug Administration; 2008. [Cited 2011 May 13]. Available from: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4398b1-01-FDA.pdf.
- Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med 2008;149:380-90. https://doi.org/10.7326/0003-4819-149-6-200809160-00004
- Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008;300:1439-50. https://doi.org/10.1001/jama.300.12.1439
- Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543-54. https://doi.org/10.1056/NEJMoa0805800
- Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP. Cardiovascular safety of tiotropium in patients with COPD. Chest 2010;137:20-30. https://doi.org/10.1378/chest.09-0011
- Michele TM, Pinheiro S, Iyasu S. The safety of tiotropium-- the FDA's conclusions. N Engl J Med 2010;363:1097-9. https://doi.org/10.1056/NEJMp1008502
- Barnes PJ. The pharmacological properties of tiotropium. Chest 2000;117(2 Suppl):63S-6S. https://doi.org/10.1378/chest.117.2_suppl.63S
- Valente S, Pasciuto G, Bernabei R, Corbo GM. Do we need different treatments for very elderly COPD patients? Respiration 2010;80:357-68. https://doi.org/10.1159/000320221
- Spiriva Handihaler package insert. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; 2010.
- Kesten S, Jara M, Wentworth C, Lanes S. Pooled clinical trial analysis of tiotropium safety. Chest 2006;130:1695-703. https://doi.org/10.1378/chest.130.6.1695
- Pedone C, Incalzi RA. Tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2009;360:185. https://doi.org/10.1056/NEJMc082265
- Chang ET. Tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2009;360:185. https://doi.org/10.1056/NEJMc082265
- O'Connor AB. Tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2009;360:185-6. https://doi.org/10.1056/NEJMc082265
- Singh S, Furberg CD, Loke YK. Tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2009;360:186.
- Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, et al. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med 2009;169:1403-10. https://doi.org/10.1001/archinternmed.2009.233
- Hochrainer D, Holz H, Kreher C, Scaffidi L, Spallek M, Wachtel H. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers. J Aerosol Med 2005;18:273-82. https://doi.org/10.1089/jam.2005.18.273
- Caillaud D, Le Merre C, Martinat Y, Aguilaniu B, Pavia D. A dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. Int J Chron Obstruct Pulmon Dis 2007;2:559-65.
- Casarosa P, Bouyssou T, Germeyer S, Schnapp A, Gantner F, Pieper M. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs. J Pharmacol Exp Ther 2009;330:660-8. https://doi.org/10.1124/jpet.109.152470
- Hansel TT, Neighbour H, Erin EM, Tan AJ, Tennant RC, Maus JG, et al. Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma. Chest 2005;128:1974-9. https://doi.org/10.1378/chest.128.4.1974
- Sato E, Koyama S, Okubo Y, Kubo K, Sekiguchi M. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol 1998;274:L970-9.